ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.68 Cr | ₹4.62 Cr | ₹4.52 Cr | ₹1.96 Cr | ₹1.63 Cr |
What is the latest Contingent Liabilities ratio of ALBERT DAVID ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹4.68 Cr |
| Mar2025 | ₹4.62 Cr |
| Mar2024 | ₹4.52 Cr |
| Mar2023 | ₹1.96 Cr |
| Mar2022 | ₹1.63 Cr |
How is Contingent Liabilities of ALBERT DAVID Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.68 Cr | 1.36 | |
| Mar2025 | ₹4.62 Cr | 2.17 | |
| Mar2024 | ₹4.52 Cr | 130.38 | |
| Mar2023 | ₹1.96 Cr | 20.22 | |
| Mar2022 | ₹1.63 Cr | - | |
Compare Contingent Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹394.7 Cr | 1.2% | -3.7% | -25.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 1.2% |
-3.7% |
-25.5% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses